Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Despite sluggish IPO market, biotechs continue to lead the way
Despite sluggish IPO market, biotechs continue to lead the way
Despite sluggish IPO market, biotechs continue to lead the way
Submitted by
admin
on July 6, 2016 - 11:11am
Source:
BioPharma Dive
News Tags:
IPOs
biotech
Reata Pharmaceuticals
Syros Pharmaceuticals
Headline:
Despite sluggish IPO market, biotechs continue to lead the way
Do Not Allow Advertisers to Use My Personal information